Will the development of the DBV-Technologies Viaskin patch enable us to bid goodbye to allergies?

Huge strides are being made in the field of epicutaneous immunotherapy. Click here if you’d like to discover more about the Paris firm that’s leading the charge.

Allergies have probably never been more prominent in the public consciousness than they are now. Well-known allergies encompass foodstuffs like seafood and cow’s milk.

DBV Technologies is seemingly well on the way to finding an EPIT-based solution to allergies – more information is available on http://www.dbv-technologies.com/en/epit.

The Viaskin patch is a simple adhesive patch worn on the skin. The crucial elements of the patch are made up of its adhesive crown next to the skin and a titanium backing.

The strategy behind this epicutaneous patch isn’t particularly complicated. Tiny amounts of the relevant allergen are sprayed upon the patch in an even coating, which then dries.The ultra-hydration of the skin by the patch solubilizes the antigens. They pass through the skin into the Langerhans cells and the tolerization of the body to the allergens in question can start.

Why not click here to see more about the Viaskin milk version of the patch?